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Abstract: Periodontal disease, a relevant public health problem worldwide, is generally considered a
common pathology of elderly people. In this respect, there is agreement about that nutritional status
may be a modifying factor in the progression and healing of the periodontal tissues. Vitamins have
been recommended as nutraceuticals for prevention and treatment of some pathological conditions,
such as cardiovascular diseases, obesity or cancer. Thus, a systematic approach to determining
how the different vitamin type could ameliorate periodontal risks or improve periodontal health is
necessary to further the understanding of the potential benefits and risks of vitamins supplementation
use. For this, a systematic review of English-written literature in PubMed until February 2018, which
included both human and animal research on the relationship of each vitamin with periodontal
disease, was conducted. Among all the analyzed vitamins those with antioxidant capacity and effects
on immune system seem to be useful for prevention or improvement of periodontal disease, as well
as those implicated in bone metabolism. In the first case, there are quite information in favor of
various vitamins, mainly vitamin C, that is the most studied. In the second case, vitamin D seems to
have the most relevant role.
Keywords: diet; gingivitis; micronutrients; nutrition; oral health; periodontitis; supplementation
1. Introduction
Periodontal disease, a relevant public health problem worldwide, is generally considered a
common pathology of elderly people [1]. In the United States (US), its prevalence is over 47%, with 64%
of adults aged 65 years and older having either moderate or severe periodontitis [2]. It is essentially a
chronic inflammatory disease caused by specific oral microorganisms (e.g., Porphyromonas gingivalis and
Aggregatibacter actinomycetemcomitans), characterized by the loss of supporting periodontal ligament
and alveolar bone and is the first cause of tooth loss [3]. Periodontal disease is influenced by many
risk factors, such as alcohol, stress, smoking, genetics, diabetes, and hormonal alteration status (i.e.,
pregnancy or menopause) [4], so that the maintenance of oral and periodontal health becomes today a
challenge, especially considering that periodontal disease can be itself a risk factor for a number of
chronic disorders. Indeed, it is generally accepted that periodontitis is strictly associated with many
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chronic diseases, such as type 2 diabetes mellitus (DM2), cardiovascular diseases, inflammatory bowel
disease and rheumatoid arthritis [5]. Therefore, there is a growing interest in the relationship between
oral health and systemic health.
Undoubtedly, oral microorganisms are indispensable for the pathogenesis of periodontal disease,
but, among risk factors, nutrition represents an influential aspect that is often neglected [1]. Indeed,
nutritional factors have a vital importance for the equilibrium between oral microorganisms and
the host response, from which depends the onset and progression of periodontal disease [6,7]. In
the past, health-focused dietary approaches have mostly focused in reducing the consumption of
“undesirable” dietary components such as sodium, refined sugars, and saturated fats. However,
attention on promoting the consumption of “curative nutrients” has been expanded. This perception of
“food or nutrient as a medicament” has encouraged the search of a growing number of new substances
categorized from dietary supplements to “nutraceuticals”, with the aim of improving human health,
making us fitter and more resilient to disease [8,9]. “Nutraceuticals” are a category of substances
without a legal definition, often sold as dietary supplements or components of conventional foods [10].
Zeisel [11] defined nutraceuticals as dietary supplements that delivers a concentrated form of a
biologically active component of food in a non-food matrix to enhance health. A dietary supplement
is a product that is intended to supplement the diet that bears or contains one or more ingredients
like, vitamin, mineral, an herb, an amino acid or a concentrate, metabolite, constituent, extract, or
combinations of these.
Because the scientific characterization and commercial regulation of such substances vary from
country to country [8,11,12], their popularity imposes the medical and scientific community a constant
revision of their therapeutic potentials. Nutritional status of the host has been widely recognized as
a possible promoting factor in many inflammatory conditions such as periodontal diseases [13,14].
Actually, the consumption of specific foods or extracts of specific foods have been shown to have
an effect on both the oral health and the general health of patients with periodontal disease [6,7,15].
Among dietary factors, those nutrients that exert antioxidant and immunomodulatory effects [6,7,16,17]
or are implicated in bone metabolism [6,7,18] could be a promising candidate for the prevention or
the management of periodontal diseases. Vitamins that have been recommended as nutraceuticals for
prevention and treatment of some pathological conditions, such as cardiovascular diseases, obesity
or cancer [6,19], could have an interesting role. In fact, they are susceptible to be delivered as
tablets or added to foods and a 20–30% of Americans currently consume multivitamin supplements
daily, indicating high public interest in the prevention of chronic diseases through a nutrition-based
approach [19].
In this context, epidemiologic studies generally evaluate foods rather than specific bioactive food
components and there is still a scarcity of reports describing any effects of dietetic interventions on
periodontitis. Thus, a systematic approach to determining how the different types of vitamins could
ameliorate periodontal risks or improve periodontal health is necessary to understand the potential
benefits and risks of vitamins supplementation. The aim of this review is to analyze the main published
data until February 2018 on the relationship between vitamins and the development and progression
of periodontal disease both in humans and animals.
2. Results and Discussion
Our initial search detected 6055 publications. Title and abstract screening left 51 potential articles
according to the inclusion and exclusion criteria. Full-text screening and reading led to a final number
of 41 articles which were included in this this review. All vitamins, except vitamin K, were represented
in the selected literature, although several studies evaluate the effects of different vitamins role
at the same time. The results from these studies concerning each vitamin, as well as their most
relevant methodological aspects for the aim of this review, are presented and discussed in separated
sections below.
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In general, evidence supporting certain grade of relationship of vitamins with periodontal health
is reduced in many cases. Most of information is provided by observational studies, particularly
cross-sectional studies, and many of them were performed in specific groups. These groups differed
in age, disease or health condition making thus difficult to translate these findings to the overall
population. In addition to that, few articles deepened on the mechanisms under the observed
relationships. Among other reasons, this could be due to methodological approach of this review.
However, there are other reasons inherent to studies investigating diet or nutrition role in a pathology
or disease outcomes [14]. For instance, possible relationships reported between nutritional status
and disease outcomes are usually non-linear and typically exhibit a threshold effect [19]. Likewise,
the methodology used to obtain data about both, dietary intakes and nutritional status, leads to other
problems. However, dietary intakes estimation methods are usually susceptible to memory errors
and bias [14]. Likewise, nutritional status biomarkers are not meaningful for certain nutrients [20].
Unfortunately, it was also not uncommon that dietary supplements also were ignored or normalized
with the same value for all subjects. Lastly, there is also a wide variability with respect to the evaluation
of periodontal health in the selected studies. Concerning this, assessed outcomes included various
clinical parameters obtaining in the oral examinations (probing pocket depth (PPD), clinical attachment
loss (CAL), bleeding on probing (BOP)), but also different indexes (Russell’s Periodontal Index (RPI),
Community Periodontal Index (CPI) or Community Periodontal Index of Treatment Needs (CPITN),
Periodontal Index (PI), or Gingival Index (GI)) as well as different disease definitions or classifications.
Likewise, number and loss of teeth were taken into account, although these depend only partially
due to periodontitis. Consequently, findings from the studies collected in this review have a complex
interpretation. This makes difficult to draw conclusions about the role of the different vitamins in
periodontal disease, particularly for those less studied.
2.1. Vitamin D
Vitamin D is an inclusive term for several forms of the hormone cholecalciferol whose biologically
active form is 1,25-dihydroxycholecalciferol (1,25(OH)2D3) [21]. This vitamin is the second most
represented nutrient among the observational studies selected in this review with a total of eight
articles (Table 1). In detail, we found four cross-sectional, three case-control and two cohort studies.
The best-known action of 1,25(OH)2D3 is regulation of plasma calcium and phosphorus levels affecting
bone development and metabolism, but it is also essential for cell development and neuromuscular
functioning [21,22]. In addition, vitamin D also has a role in the immune system and inflammation,
inhibiting pro-inflammatory cytokines and T-lymphocyte proliferation, at least in vitro [23]. Actually,
antigen-presenting cells, macrophages and lymphocytes express a nuclear receptor for vitamin D.
Activities on both, bone and immune system, result interesting for periodontal disease prevention and
management since they would be useful preserving alveolar bone and gingival tissue. In contrast with
other vitamins, animals can endogenously produce vitamin D by conversion of 7-dehydrocholesterol
found in the skin into pre-vitamin D after exposure to the sun [24]. Thus, sun exposure notably
influences RDA [25]. For this reason, vitamin D status is best determined by the level of serum or
plasma 25-hydroxyvitamin D (25(OH)D), which reflects the total contribution from both dietary and
endogenous sources. Here, most of selected observational studies assessed nutritional status for this
nutrient by 25(OH)D levels in blood, although dietary intakes were estimated in two of the selected
cross-sectional studies.
Most interesting results were provided by a 20 year longitudinal study in the U.S. known
as the Health Professionals Follow-Up Study, where predicted 25(OH)D score was inversely and
dose-dependently associated with self-reported tooth loss and periodontal disease [26]. However,
participant ages ranged from 40 to 75 years old. This has been supported by a cross-sectional study
conducted on a sample of 11,202 subjects participating in NHANES III reported an inverse association
between serum 25(OH)D and CAL in men and women, but only in subjects over 50 years old in
both genders [27]. In this sense, a cross-sectional study in a male relatively aged segment (62.9 ±
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7.6 years), but with a more reduced ample size (N = 562) also suggest this an inverse association
between vitamin D intake and severe periodontitis according to American Academy of Periodontology
(AAP) criteria. A similar association was found for moderate-to severe ABL (i.e., 40% of ABL at
three or more sites) calculated from conventional periapical radiographs [28]. These studies are in
consistency with the previous study and, along with it, point out adults at middle or higher age as
risk group where correct vitamin D intake could have a key role in periodontal health maintenance.
Similarly, a case control study with a more reduced sample of periodontitis-affected and periodontally
healthy subjects from Puerto Rico has reported a associations between serum levels of 25(OH)D
and periodontal condition [29]. In contrast, no significant association was found in a cross-sectional
study in a representative sample of Denmark [30]. Likewise in other cross-sectional study performed
on participants in fourth Korea National Health and Nutrition Examination Survey (KNHANES)
evaluating association between vitamin D deficiency, in this case determined by serum levels, and
prevalence of periodontitis defined by a CPI of 3 or higher in 6011 individuals [31]. However, no
association was observed. On the other hand, stratified analyses revealed a significant association
in current smokers [31]. Absence of association in one of these studies could be due to periodontal
health measure since CAL or CPI that is based in PPD and can under evaluate bone loss. Still, this last
study suggest that vitamin D could be of important for periodontal health in smokers as occurred for
other vitamins.
Combined results from all previous studies suggest that starting to take vitamin D supplementation
from middle age could be particularly interesting for preventing periodontal disease advancement.
This was expected given the role of vitamin D in bone metabolism as well as role of age as risk factor
for bone health maintenance. In this sense, several studies have been performed on subgroups with
conditions that represent a risk for bone health. In relation to age, two studies were only focused
on postmenopausal women but reported association depending on parameter using to evaluate
periodontal health or nutritional status. These included a cohort study [32] where no significant
associations were found after a 5 year follow-up period with different parameters related to periodontal
health. Included parameters were alveolar crestal height (ACH), CAL, PPD and % BOP. Results did
not confirm any association with 25(OH)D levels. In contrast, an inverse association was found in a
cross-sectional study in which two definitions of periodontal disease, one based on ACH measures and
tooth loss and the other based on CDC/AAP criteria, were used [33]. Likewise, acute oral inflammation
was assessed by percentage of BOP and they found that 42% of same group showed lower odds of
having 50% of gingival sites that bled or more. Lastly, pregnancy also has been taken into account in a
case-control study. In this, women with clinically moderate to severe periodontal disease presented
lower levels and higher prevalence of vitamin deficiency than periodontal healthy women [34].
According to these results, recommendations of vitamin D (and probably calcium)-supplements
use for people under physiological or pathological conditions that increase the risk of suffers bone
pathologies or pathological alterations, also could contribute to protect periodontal tissues.
Interestingly, in a case-control study that discriminated between patients with generalized
aggressive periodontitis and chronic periodontitis, it was noted higher plasma calcifediol levels in
patients with aggressive periodontitis compared with healthy controls, but not in chronic periodontitis
cases [35]. Additionally, partial intra-groups correlations with main clinical outcomes (PPD, CAL,
bleeding index, % surfaces with BOP) were analyzed and it was found a positive association with
BI in this group. Confounding could be explained by the differences among these studies. The first
case-control did not evaluate possible confounding effects for skin color or sun exposure (while data
collected over a 6 years period) that showed differences between groups when they were analyzed in
the second case besides civil status, weight, medical insurance [34]. This could lead to underestimate
towards null the associations with chronic periodontitis. On the other hand, aggressive periodontitis
was not considered in the third investigation and it showed inverse relationships with vitamin D
compared to more common periodontal disease or chronic periodontitis, although different etiology
could be responsible.
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Table 1. Observational studies on vitamin D association with periodontal disease.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional
Status
Assessment
Periodonta Status Analysis Results(p-Value)
Main
Results/Conclusions Ref.
CS
DANHES 2007–2008
participants (Denmark)
Both; ≥18 y;
N = 3287
Vitamin D intake by
FFQ
-
Severe
periodontitis 1 N.S. (mult. logistic reg.)
No association [30]
CAL N.S. (mult. linear reg.)
CS DLS participants (USA) Male; 62.9 ± 7.6 y;
N = 562
Daily dietary intake
(≥400 IU, 400–800 IU
or ≥800 IU) by FFQ
-
Severe
periodontal
disease 1
OR 1 = 0.67 (95%CI:
0.55–0.81); p < 0.05 for
trend (mult. logistic reg.)
Inverse
associations
[28]
Moderate to
severe ABL 2
OR 1 = 0.54 (95%CI:
0.30–0.96); p < 0.05 for
trend (mult. logistic reg.)
CS
NHANES III participants
(USA)
Both; ≥20 y;
N = 11,202
-
Serum levels of
25(OH)D
(quintile)
Mean CAL
N.S. (mult. linerar reg.) in
men <50 y old
Negative
association with
CAL, only in
subjects ≥50 years
[27]
CAL 2 = +0.39 mm (95%CI:
0.17–0.60); p = 0.001 (mult.
linerar reg.) in men
≥50 y old
N.S. (mult. linerar reg.) in
women <50 y old
CAL 2 = +0.26 mm (95%CI:
0.09–0.43); p = 0.008 (mult.
linerar reg.) in women
≥50 y old
% BOP N.S. (mult. linerar reg.) inall subsets
CS
4th KNHANES
Participants (South Korea)
Both; ≥19 y;
N = 6011
-
Serum levels of
25(OH)D (>20,
<20 ng/mL)
deficiency
CPI ≥ 3
N.S. (mult. logistic reg.) in
non-restricted model
Inverse
association only in
current smokers
[31]
OR 2 = 1.53 (95%CI:
1.07–2.18) (mult. logistic
reg.) in model resticted to
current smokers
N.S. (mult. logistic reg.) in
model restricted to
non-current smokers
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Table 1. Cont.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional
Status
Assessment
Periodonta Status Analysis Results(p-Value)
Main
Results/Conclusions Ref.
CS
Paticipants in OsteoPerio
Study (USA)
Female,
Postmenopause;
N = 920
-
Plasma levels of
25(OH)D
(Adequate or
inadequate
nutritional status)
50% BOP
OR = 0.42% (95%CI:
21–58%); p < 0.05 for
trend
Inverse
association with %
BOP &
periodontal
disease according
to CDC/AAP
criteria 5
[33]
periodontal
disease based on
ACH measures 3
N.S.
periodontal
disease based on
CDC/AAP
criteria 1
OR = 33% (95%CI:
5–53%) p < 0.05 for trend
tooth loss N.S.
CC
Subjects from an
University Health Center
(China)
Both; 16–64 y;
N = 178 -
Plasma levels of
25(OH)D
Aggressive
periodontitis 4 vs.
chronic
periodontitis-affected
4 vs. healthy
(Staff)
29.28 in aggressive
periodontitis patients
>21.60 nmol/L in
controls; p < 0.05
(ANCOVA)
Plasma 25(OH)D
levels in patients
with aggressive
periodontitis were
higher than those
of healthy controls
[35]
CC
Women with a singleton
pregnancy taking vitamin
D supplements (USA)
27 ± 6 for
cases/31 ± 6 y for
controls; N = 235
-
Serum levels of
25(OH)D
Clinical moderate
to severe
periodontal
disease-affected 5
vs. healthy
59 > 100 nmol/L;
p < 0.001 (Wilcoxon
Mann-Whitney U)
Subject with
periodontal
disease had lower
serum levels of
25(OH)D
[34]Women with
vitamin D
deficiency
(<75 nmol/L)
65 > 29%; p < 0.001) (x2
Test). Moreover,
multivariable analysis
showed an adjusted OR
of 2.1 between
periodontal disease and
vitamin D insufficiency
(95%CI. 0.99–4.5)
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Table 1. Cont.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional
Status
Assessment
Periodonta Status Analysis Results(p-Value)
Main
Results/Conclusions Ref.
CC
Cases of moderate/severe
periodontitis &
periodontally healthy
controls aged. (Puerto
Rico, USA)
Both; 35–64 y;
N = 38
-
Serum levels of 25
(OH) D levels
periodontal
disease
18.5 (± 4.6) ng/mL <
24.2 (± 7.1) ng/mL;
p = 0.006. Inverse
association
[29]
Serum levels of 25
(OH) D levels
OR = 0.885 (95%CI:
0.785–0.997) p < 0.05
for trend
C (5 y)
Postmenopausal
paticipants in OsteoPerio
Study (USA)
Female;
Postmenopause;
N = 665
- Plasma levels of
25(OH)D
Mean ACH
increase (1 mm) N.S. (mult. linear reg.)
No association [32]
Mean CAL
increase (1 mm) N.S. (mult. linear reg.)
Mean PD increase
(1 mm) N.S. (mult. linear reg.)
Mean % BOP
increase (1%) N.S. (mult. linear reg.).
C (20 y)
Health Professionals
Follow-Up Study
participants (USA)
Both; 40–75 y;
N = 42,730
Semi-quantitative FFQ
Predicted
25(OH)D score 6
(quintiles)
Tooth loss
incidence
HR = 0.90 (95%CI:
0.88–0.92); p < 0.001 for
trend (COX model) Inverse
dose-dependent
associations
[26]
Self-reported
periodontitis
HR = 0.91 (95%CI:
0.86–0.95); p < 0.001 for
trend (COX model)
1 values compared highest vs. lowest percentile, 2 values compared lowest vs. highest percentile, 1 AAP/CDC criteria: PPD ≥ 5 mm on at least 1 tooth and CAL ≥ 6 mm at 2 or more sites
(not on same tooth), 2 ABL ≥ 40% at 3 or more sites. 3 ABL ≥ 40% or ≥1 tooth lost, 4 IWCPDC criteria: 3 BOP & PPD ≥ 3 mm at ≥1 sites. AL > 2 mm or ≥1 tooth lost, 5 ≥15 sites with PPD
≥4 mm. Abbreviations: 95%CI: 95% confidence interval, 25(OH)D: 25-hydroxyvitamin D, AAP: American Academy of Periodontology, ABL: alveolar bone loss, ACH: alveolar crestal
height, BOP: bleeding on probing, CAL: clinical attachment loss, CC: case-control study, CDC: Center for Disease Control and Prevention, CS: cross-sectional study, DLS: Department of
Veteran Affairs Dental Longitudinal Study, HR: hazard ratio, IWCPDC: International Workshop for the Classification of Periodontal Diseases & Conditions in 1999, NHANES III: Third
National Health and Nutrition Examination Survey, OR: odds ratio, PPD: periodontal probing pocket, US: United States, vs.: versus, w: weeks.
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2.2. Vitamin A
Vitamin A is a liposoluble vitamin can be present in different forms including retinol (A1), retinal,
3,4-dehydroretinol (A2) and 3-hydroxyretinol (A3). However, it his known that about 50 possible
carotenoids (a group lipid-soluble plant pigments) act as vitamin precursors, being β-carotene the
most important. For this reason, it was also selected studies assessing levels or intake of carotenoids
with provitamin A activity (mainly α- and β-carotene, and β-cryptoxanthin). Attending to that,
seven publications were collected, although they contain only observational studies (Table 2), mostly
cross-sectional studies. Among them, only three studies estimated dietary intakes of vitamin A. On
one hand, Freeland et al. [36] reported a significant negative correlation at bivariate level between
vitamin A intake and RPI in a smaller sample constituted by patients from a suburban dental
clinic. Notwithstanding, these authors also analyzed the relationship with more nutrients and
vitamin A intake was not considered among significant predictors in multiple analysis after using
R2 improvement. Additionally, dietary intake data only were available from 56 of 80 patients, which
could produce a selection bias that was no evaluated. On the other hand, a case-control study in female
adolescent with and without gingivitis indicates absence of differences for both, intake or prevalence
of marginal deficiencies of intake (below one third of recommendations) [37]. However, in the two
first studies, dietary intakes were estimated by a 24 h recall and a 3 days food diary, respectively. Such
information only represents current diet, which along with the possible memory errors and bias may
not represent real nutritional status of the sample [20]. Anyway, most of studies have investigated
possible associations of serum levels of vitamin A (or retinol) and different carotenoids with periodontal
health. Results from one of these investigations are particularly significant due to it was performed with
a sample of 11,480 adults from the third National Health and Nutrition Examination Survey (NHANES
III), which are a representative of the United States (US) non-institutionalized population [38]. In
this, significant associations with periodontitis were reported for α-, β-carotene and β-cryptoxanthin
when analysis was not restricted to most severe cases of periodontitis (defined by the presence of
at least one site with CAL of 4 mm or higher and PPD of at least 4 mm). Still, severe periodontitis
(defined by the presence of two or more mesiobuccal sites with CAL of at least 5 mm and at least
one mesiobuccal site with PPD of 4 mm or higher) was significantly associated with β-carotene and
vitamin A [38]. In contrast, no significant associations with RPI was reported by the study in patients
from a suburban dental clinic recently mentioned [36]. Moreover, as indicated, vitamin A intake was
also not related to RPI in multiple analysis in the same study. Anyway, it is important to point out that
blood samples were collected after no fasting indication in the last study. The combination of all this
methodological issues along with the reduced subset of individuals evaluated would contribute to
explain the absence of significant associations found in this study. In spite of most studies has been
considered to evaluate vitamin A nutritional status by measurement of blood levels, there was also a
study in an ethnic group from Sri Lanka that evaluated it by means of deficiency clinical symptoms
presence, but no association was also found with RPI again [39]. However, in this last periodontal
disease degree could be undervalued since oral examinations outside of University were made into
bad conditions such as poor luminosity and non-appropriate chairs, among others. Despite these
results, it is important to point out that Vitamin A is stored in the liver and serum levels are closely
regulated, so low and deficient serum values are linked to depleted hepatic stores [40].
Other known risk factors have been also taken into account in many of the selected studies,
especially age and smoking. Some studies have been performed only in elderly adults. These
include a retrospective cohort study in 334 Japanese from Niigata city where dietary intakes of α- and
β-carotene were estimated by a brief self-administered diet-history questionnaire (BDHQ) [41], and a
cross-sectional in 1258 PRIME study participants (North Ireland) where serum levels of retinol, α and
β-carotene, and β-cryptoxanthin were registered [42]. In spite of the first one only was focused in two
carotenoids, it was noted a negative association between dietary β-carotene intake and no of teeth with
periodontal disease progression, even after adjustment for several cofounders, although α-carotene
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intake did not show association [42]. Unfortunately, the BDHQ did not include supplements and it
was self-assessed.
Notwithstanding, the role of β-carotene was supported by results from the second study that
was carried out in a sample with a considerable size. This also suggests an important role for
β-cryptoxanthin, as well as for α-carotene and retinol, but only when analysis were not restricted to
more severe periodontitis cases. However, it is important to point out that participants were only
men in the last one. Concerning smoking, in the study performed on data from NHANES III [38]
only β-carotene levels maintain an inverse association with periodontitis when analysis was restricted
to never-smokers. In this context, other studies adjusted OR by age or include smoking status as
covariate in multiple models. This emphasizes the importance of these risk factors in periodontal
health as well as their interaction with this group of nutrients. This suggests the existence of putative
risk groups to recommend the consumption of vitamins A or pro-vitamins as nutraceutical in the
context of periodontal health. However, the methodological approaches of the mentioned studies
makes provided evidence no definitive to consider this group of nutrients as “nutraceutical” and some
additional experimental, or at least cohort, studies are needed.
The biologically active form of vitamin A, retinoic acid, is essential for maintaining the integrity
of mucosal tissues and for proper differentiation of cells, including those of the immune system [28,43].
According to this, it is expected that an adequate intake of this nutrient prevent periodontal
disease onset or progression since it affect to connective tissue maintenance. Moreover, its role
in immune system could be also important for maintain some bacteria adequate level and for prevent
over-inflammation. However, as neither indicated studies specifically evaluating vitamin A intake
did not support this [36,37]. In spite of this might mean a virtual absence of relationship between
this nutrient and periodontal health, it is also important to consider that none divided sample by
recommended dietary amount. Consequently, if deficiencies are rare in populations where the studies
were carried out, relationship could be not be elucidated when this is not linear. Moreover, other
investigators have reported antioxidant activities for retinol and dehydroretinol as well as for many
pro-vitamin A compounds, including β- and α-carotenes [44,45]. However, β-carotene is an efficient
quencher of singlet oxygen [46] but vitamin A (i.e., retinol and derivatives) cannot quench singlet
oxygen and has a very small capacity to scavenge free radicals [47,48]. In addition, more studies
and analysis reported associations for β-carotene than for retinol or vitamin A. This fact would be
consistent with the possibility that this effect is due to its antioxidant activity and not as vitamin
A precursor. Unfortunately, there were no measurements of oxidative stress levels in the studies
presented in this review.
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Table 2. Observational studies on association of vitamin and provitamins A with periodontal disease.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional Status
Assessment Periodontal Status Analysis Results (p-Value) Main Results/Conclusions Ref
CS Dental clinicpatients (USA)
Both; N.A.;
N = 80
Dietary intakes of
vitamin A by 24-h
recall (N = 56)
Serum levels of
vitamin A RPI
N.S. (mult. linear reg with R2
improvement) No associations [36]
CS Ethnic groupsubjects (Sri Lanka)
Both; ≥13 y;
N = 7944 -
Vitamin A deficiency
determined by
clinical symptoms
RPI N.S. (mult. linear reg.) No association [39]
CS
NHANES III
participants (USA)
Both; ≥20 y;
N = 11,480
-
Serum levels of
α-carotene
(quintiles)
Mild periodontitis 3
OR 1 = 0.60 (95%CI: 0.46–0.77);
p = 0.0009 for trend (mult. logistic reg.)
in non-restricted model
Negative association of β-&
α-carotene, &
β-Cryptoxanthin with mild
periodontitis; & of
β-carotene & vitamin A
with severe periodontitis
[38]
N.S. (mult. logistic reg.) in model
restricted to never-smokers
Severe periodontitis 4 N.S. (mult. logistic reg.) in both models
Serum levels of
β-carotene
(quintiles)
Mild periodontitis 3
OR 1 = 0.80 (95%CI: 0.65, 0.98);
p = 0.0001 for trend (mult. logistic reg.)
in non-restricted model
OR 1 = 0.99 (95%CI: 0.73–1.35);
p = 0.044 for trend (mult. logistic reg.)
in model restricted to never-smokers
Severe periodontitis 4
OR 1 = 0.65 (95%CI: 0.46–0.93);
p = 0.001 (mult. logistic reg.) in
non-restricted model
N.S. (mult. logistic reg.) in model
restricted to never-smokers
Serum levels of
β-cryptoxanthin
(quintiles)
Mild periodontitis 3
OR 2 = 0.74 (95%CI: 0.61–0.89) p = 0.03
for trend (mult. logistic reg.) in
non-restricted model
N.S. (mult. logistic reg.) in model
restricted to never-smokers
Severe periodontitis 4 N.S. (mult. logistic reg.) in both models
Serum levels of
vitamin A (quintiles)
Mild periodontitis 3 N.S. (mult. logistic reg.) in both models
Severe periodontitis 4
OR 1 = 0.77 (95%CI: 0.58–1.03) p = 0.049
for trend (mult. logistic reg.) in
non-restricted model
N.S. (mult. logistic reg.) in model
restricted to never-smokers
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Table 2. Cont.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional Status
Assessment Periodontal Status Analysis Results (p-Value) Main Results/Conclusions Ref
CS
Participants in
PRIME (Northern
Ireland)
Male; 60–70 y;
N = 1258
-
Serum levels of
retinol (quintiles)
Low-threshold
periodontitis 5
OR 2 = 1.64 (95%CI: 1.07–2.51);
p = 0.008 for trend (mult. logistic reg.)
Negative association of
serum levels of β-carotene
& β-cryptoxanthin at both
tresholds, & also of
α-carotene only at
low-threshold
[42]
High-threshold
periodontitis 6 N.S. (mult. logistic reg.)
Serum levels of
α-carotene
(quintiles)
Low-threshold
periodontitis 5
OR 2 = 1.81 (95%CI: 1.17–2.82); p < 0.001
for trend (mult. logistic reg.)
High-threshold
periodontitis 6 N.S. (mult. logistic reg.)
Serum levels of
β-carotene
(quintiles)
Low-thresholdperiodontitis
5
OR 2 = 1.83 (95%CI: 1.19–2.80); p < 0.001
for trend (mult. logistic reg.)
High-threshold
periodontitis 6
OR 2 = 1.87 (95%CI: 0.86–4.06); p = 0.01
for trend (mult. logistic reg.)
Serum levels of
β-cryptoxanthin
(quintiles)
Low-threshold
periodontitis 5
OR 2 = 1.50; 95%CI: 0.99–2.27); p = 0.02
for trend (mult. logistic reg.)
High-threshold
periodontitis 6
OR 2 = 4.02 (95%CI: 1.61–9.99); p = 0.001
for trend (mult. logistic reg.)
CC
Non-smokers
adolescents (Italy)
Female; 17–19 y;
N = 54
Dietary intake of
vitamin A by 3-d
record
- Gingivitis affected
7 vs.
non-affected
N.S. differences between groups
(Student t test)
No association [37]Dietary intake
marginal deficiency
(<1/3 RDA) of
vitamin A by 3-d
record
N.S. (X2 test with Yates correction)
RC (2 y) Niigata studyparticipants (Japan)
Both; 75 y;
N = 334
Dietary intakes of
α-carotene (tertiles)
by BDHQ
-
No. of teeth with
periodontal disease
progression 8
N.S. (mult. logistic reg.)
Negative association with
β-carotene intake [41]Dietary intakes of
β-carotene (tertiles)
by BDHQ
IRR 1 = 0.73 (95%CI: 0.56–0.95); p < 0.05
for trend (mult. logistic reg.)
1 values compared highest vs. lowest percentile, 2 values compared lowest t vs. highest percentile, 3 at least 1 site with CAL ≥4 mm & PPD ≥4 mm, 4 ≥2 mesiobuccal sites with CAL ≥5
mm & 1 mesiobuccal sites with PPD ≥4 mm, 5 at least 2 teeth with non-contiguous inter-proximal sites with CAL ≥6 mm & 1 PPD of ≥5 mm, 6 ≥15% of all sites measured CAL ≥6 mm &
there was at least one site with PPD ≥6 mm, 7 ≥1 site with BOP, 8 CAL ≥ 3 mm in ≥1 site. Abbreviations: 95%CI: 95% confidence interval, BDHQ: brief diet-history questionnaire, BOP:
Bleeding on probing; C: Cohort study, CAL: Clinical attachment loss, CPI: Community periodontal index; CS: Cross-sectional study; d: days, h: hours, IRR: incidence rate ratio, mult.:
multiple, N: sample size, N.S.: not significant, NHANES III: Third National Health and Nutrition Examination Survey, OR: Odds ratio, PRIME: Prospective Epidemiological Study of
Myocardial Infarction, PPD: periodontal pocket depth, RC: retrospective cohort study, RDA: recommended dietary amount, Ref: reference, reg.: regression, RPI: Russell’s Periodontal
Index, SD: Standard deviation; US: United states, vs.: versus, y: years.
Molecules 2018, 23, 1226 12 of 29
2.3. Vitamin B-Complex
Vitamin B-complex refers to all of the known essential water-soluble vitamins except for vitamin
C. These include thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), pantothenic
acid (vitamin B5), pyridoxine (vitamin B6), biotin (vitamin B7 or B8), folic acid (vitamin B9) and
cobalamin (vitamin B12) [49]. Four observational studies in humans, three cross-sectional studies and
a case-control study met the eligibility criteria for vitamins belonging to B-complex. Concerning to
experimental research there was only one report focusing on a nutritional intervention in human
beings [50]. Overall, vitamin B-complex is necessary for cell growth and metabolism [49], but each
member of the B-complex has a unique structure and performs unique functions. Vitamins B1, B2, B3,
and biotin participate in different aspects of energy production, vitamin B6 is essential for amino acid
metabolism, and vitamin B12 and folic acid facilitate steps required for cellular division [50–52].
The most promising results for this group of nutrients has been offered by a randomized
placebo-controlled double-blind trial (Table 3) where it was tested the effect of a vitamin B-complex
supplement (50 mg of B1, B5, B2, B3, and B6; 50 µg of B12 and B7; and 400 µg of B9) after access flap
surgery. After 30 days of treatment, the supplement led to statistically significant superior CAL gains
when compared to placebo, although PPD improved in a similar manner in all groups [50]. However,
currently it is assumed that PPD alone does not reliably reflect whether teeth have progressive CAL,
except in sites with deep PPD. This would support the use of vitamin B-complex supplements as
nutraceutical to restore periodontal health, at least in combination with surgical interventions.
On the other hand, no associations were observed in the older investigation that analyzed
clinical sings of vitamin B deficiency in relation to RPI previously indicated for vitamin A [39].
However, as mentioned, in this last periodontal disease degree could be undervalued since some oral
examinations were made into bad conditions. Notwithstanding, more studies exploring the use of
vitamin B-complex as nutraceutical under different conditions are needed prior to encourage its use in
relation to periodontal disease.
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Table 3. Experimental studies on vitamin effects on periodontal disease.
Subjects/Animals; Age; N Experimental Design (Duration) Results Data (p-Value) Main Results/Conclusions Ref.
RCT (DB) B-complex supplement for 30 d (50 mg
of B1, B5, B2, B3, and B6; 50 µg of B12 and B7; and
400 µg of B9) after access flap surgery (180 d)
∆CAL: 0.41 > −0.52 mm (p = 0.024) B-complex led to superior CAL gains when
compared to placebo whereas PPD improved
in similar manner among groups
[50]
∆PPD: −1.50 ± 0.21 = −1.57 ± 0.34 mm (N.S.)
Calculus formers from Staff & patients
from a Faculty of Odontology (Sweden);
Age not provided; N = 60
Chew on 0 or 5 sugar free gum/day contained 60
mg or 0 mg vitamin C (CO) (3 m per treatment)
Calculus index, Erosion scores, GB, visible PI, & saliva
secretion rates (p < 0.05)
Vitamin C & non-vitamin gum reduced
visible plaque, but No. of bleeding sites only
with the first one
[53]
Children with ≤1 fully erupted tooth
following routine prophylaxis; 5–20 y; N
= 267
Chew on tablets containing vitamin C or mannitol
(DB) (28 d) RPI (N.S.) Teeth lost (N.S.) No effect [54]
Chronic periodontitis patients with ≤20
teeth receiving non-surgical treatment &
health Subjects (Syria); 23–65 y; N = 60
Adjunctive dose of vitamin C or none (4 w after
non-surgical treatment) Plasma TAOC, PPD, CAL, % BOP, PI & GI
Non-surgical treatment increases plasma
TAOC & improves clinical measures, but
vitamin C supplements have no effect
[55]
Patients with vary degrees of gingivitis
(USA); 25–60 y; N = 41
Vitamin C-supplemented or non-supplemented
diet (14 d), after receiving scaling & curettage
therapy in one quadrant or not
Levels of vitamin C in blood & gingiva, microscopy
evaluation of gingival biopsies
Vitamin C supplementation increased
Vitamin C levels in blood [56]
Male Wistar rats; 8 w; N = 35
Ligatures placement or not placement (6 w)
combined or not with vitamin C supplementation
(last 2 w)
Plasma levels of vitamin C & ROM, gingival
GSH/GSSG & levels of 8-OhdG
Genetic expresion study in gums 1
Vitamin C increased plasma vitamin C level,
improved GSH/GSSG & decreased 8-OHdG
level (61% lower) & down-regulated some
inflammation genes expression (p < 0.01)
[57]
Male Wistar rats; N.A.; N = 36
Ligatures placement or not placement (7 w)
combined or not with supplemens of vitamin C
(last 2 w)
Serum levels of BAP, gingival MPO activity, RANKL
expression, BDI in mandible
Either supplement led to lower MPO activity,
& RANKL expression, but higher AP; &
improved BDI at the periodontitis areas
[58]
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Table 3. Cont.
Subjects/Animals; Age; N Experimental Design (Duration) Results Data (p-Value) Main Results/Conclusions Ref.
Male Wistar rats; 8 w; N = 24
1 or 2 folds vitamin C-supplemented
high-cholesterol diet, non-supplemented, or
standard diet (12 w)
Alveolar BMD, TRAP-positive osteoclastic cells &
8-OHdG level in periodontal tissues
8-OHdG (1663 & 1675 mg/cm in vitamin C groups vs.
1430 (−80) mg/cm in cholesterol group, p < 0.001 and
vs. 1556 mg/cm in control groups, p < 0.05), osteoclast
differentiation (1.1 & 0.8 vs. 4.2 No. of tartrate-resistant
acid phosphatase [TRAP]-positive osteoclasts/0.1 mm,
p < 0.05) &decreased serum 8-OHdG expression (0.12
& 0.10 vs. 0.14 ng/mL, p < 0.05)
Vitamin C supplements reduced the effect of
high-cholesterol diet on BMD, osteoclast
differentiation & decreased 8-OhdG and
osteoclast differentiation kit
[59]
Male rats with non-osteogenic
hereditary disorder (ODS od/od) &
without it (ODS +/+); 5 w; N = 28
Vitamin C-deficient, minimally supplemented or
sufficient supplemented diet in non-osteogenic
disorder group (4 w)
Plasma level of vitamin C, histological observations of
periodontium, BMD & cephalometric evaluation
Vitamin C deficiency influenced periodontal
ligament & craniofacial growth [60]
Male Wistar rats; 180–220 g; N = 72 Vitamin E supplements or placebo; combinedwith ligatures placement or sham-operations (9 d)
ABL & malondialdehyde formation, SOD activity,
iNOS & TNF-α levels (1.89 ± 0.35 vs. 3.13 ± 0.42 mM
of malondialdehyde, p < 0.01)
Vitamin E prevented malondialdehyde
formation & reduced the immunoreactivity
to iNOS levels
[61]
Male rice rats; 92–119 d; N = 32
Vitamin E supplemented or non-supplemented
diet (122 d), combined with stress by a rotational
device (last 90 d)
ABL (0.369 ± 0.091 vs. 0.436 ± 0.036 mm of CEJ-ABC,
p = 0.017),
Vitamin E had a protective effect on bone loss
which was most pronounced at sites most
susceptible to loss
[62]
1 Genetic expression analysis for 86 genes implicated on: oxidative or metabolic stress, heat shock, proliferation and carcinogenesis, growth arrest and senescence, and necrosis or apoptosis.
Abbreviations: 8-OHdG: 8-hydroxydeoxyguanosine, ABL: alveolar bone loss; BAP: bone alkaline phosphatase, BDI: Bone Density Index, BI: Bleeding index, BMD: Bone mass density, BOP:
Bleeding on probing, CAL: Clinical attachment level, CO: Cross-over, d: days, DB: Double-bind, GB: gingival bleeding, GI: Gingival index, GSH/GSSG: reduced glutathione to oxidized
glutathione ratio, IL: Interleukin, iNOS: Inducible nitric oxide synthase, m: moth, MPO: Myeloperoxidase, ODS: Osteogenic disorder Shionogi, PI: Plaque index, PPD: Periodontal probing
depth, RANKL: Receptor activator of nuclear factor κB ligand, RCT: Randomized controlled trial, ROM: Reactive oxygen metabolites, RPI: Russell’s periodontal index, SOD: Superoxide
dismutase, TAOC: total antioxidant capacity, TNF-α: Tumor necrosis factor alpha, TRAP: Tartrate-resistant acid phosphatase, US: United Sates of America, w: weeks, y: years.
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There is little information about the separate role of the different components of this complex,
although observational studies provide some information in this sense (Table 4). Among all vitamins of
the B-complex, folic acid seems to be the most interesting. Actually, two of the selected cross-sectional
studies for vitamin B-complex only evaluated associations with this vitamin, but when their results are
combined, a clear association cannot be established. One performed with data from elderly participants
from the 2001–2002 National Health and Nutrition Examination Survey (NHANES) showed that low
serum folate level was independently associated with periodontal disease (defined by the presence of
at least of 10% of sites with CAL of 4 mm or higher and/or PPD of at least 3 mm) [63]. In contrast,
in other study based on a representative sample of adults from Japan, no association between risk of
periodontal disease (defined by a CPI of 3 or more) and dietary intake estimations was found [64].
Similarly, another study that only included non-smokers subjects [65] reported no correlation of dietary
intake with CPI score (i.e., periodontal disease severity) although it was inversely associated with
percentage of sites with BOP. Despite low values of CPI reflect gingival bleeding and calculus, when
it reach values of 3 or higher is only based on PPD and provides no information about bleeding or
calculus presence. Therefore, the last study suggests that folic acid intake could be important for
prevention of gingival inflammation, although the relationship with periodontal pocket formation and
development is unclear. Notwithstanding, in this study only were included non-smokers individuals.
In addition, they were adults belonging to any age. This could indicate that smoking and age and
important risk factor interacting with vitamin B9, but bias associated with dietary intake assessment
methods also could lead to underestimating the effect of this nutrient.
The role in periodontal disease of other vitamins belonging to B-complex has been also evaluated
in an observational study but no clear association has been found for them. In the study carried out
in patients from a dental clinic [36], there was no correlation between RPI (that scored the presence
and severity of both gingival bleeding and pocket depth) and the dietary intakes of the three vitamins
measured, thiamine, niacin and riboflavin. The same vitamins were also analyzed in the study
in female adolescents from Rome already mentioned for vitamin A with results that could results
interesting to clarify their roles of some vitamin B, at least at gingival inflammation level. In this
case, gingivitis-affected presented lower dietary intakes of vitamins B1 and B2 with respect to those
non-affected, but B2 was the only that remained significant in multiple logistic regression analysis.
This only occurred in one of the models used in that fiber was not included, whereas in the other two
that did it, Vitamin B2 was substituted by calcium. Authors concluded that both nutrients as strong
correlated as consequence of high milk intake, so real cause for this association remain unclear [37].
Moreover, association with dietary intake of vitamin B12 was also evaluated in the study based on a
representative sample of Japanese adults, but no significant results were reported [64]. Therefore, the
paucity of studies on individual vitamins B role in periodontal health does not allow recommending
supplementation with a particular vitamin B with a nutraceutical objective, although folic acid is
an important candidate. In any case, the results from the RCT with B-complex supplement [50] are
promising and more studies in human should be done with such combination.
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Table 4. Observational studies on vitamin B-complex association with periodontal disease.
Study
Type Sample Sex; Age; N Dietary Intake Assessment
Nutritional Status
Assessment Periodontal Status Analysis Results (p-Value)
Main
Results/Conclusions Ref
CS NHANES 2001/02Participants (US) Both; ≥60 y; N = 844 -
Serum levels of
vitamin B9
(quartiles)
Periodontal disease 2
OR 1 = 0.28 (95%CI: 0.30–1); p
= 0.03 for trend (mult. logistic
reg.)
Negative association [63]
CS
Non-smokers adults
(Japan) Both; ≥18 y; N = 497 Dietary intake of vitamin B9 -
CPI N.S. (mult. logistic reg.) Negative association
with % BOP
[64]
% BOP β= −0.204; p < 0.001 (mult.logistic reg.)
CS NHANESparticipants (Japan)
Both; ≥20 y;
N = 3043
Dietary intake of vitamins B9
& B12 by FFQ
- CPI = 3–4 N.S. (mult. logistic reg.) No associations [65]
CS Dental clinicpatients (US) Both; N/A; N = 80
Dietary intakes of vitamins B1,
B2 & B3 (N = 56)
- RPI N.S. (mult. linear reg. with R
2
improvement) No associations [36]
CS
Subjects from an
ethnic group (Sri
Lanka)
Both; ≥13 y;
N = 7944 -
Vitamin B deficiency
determined by
clinical symptoms
RPI N.S. (mult. linear reg.) No association [39]
CC
Non-smokers
adolescents (Italy)
Female; 17–19 y;
N = 54
Dietary intakes of vitamin B1
by 3-d record
- Gingivitis affected
3 vs.
non-affected
0.6 (±0.2) < 0.9 (±0.3) mg/d;
p = 0.001 (Student t test)
Negative association
with vitamin B2
intake
[37]
N.S. (Stepwise Mult.
logistic reg.)
Dietary intakes of vitamin B2
by 3-d record
1.1 (±0.3) < 1.4 (±0.3) mg/d;
p = 0.0009 (Student t test)
OR = 0.06 (96%CI: 0.01–0.35);
p = 0.002 (Stepwise Mult.
logistic reg.)
Dietary intakes of vitamin B3
by 3-d record N.S. (Student t test)
Dietary intakes marginal
deficiency (<2/3 RDA) of
vitamin B1 by 3-d record
51.9 > 22.2%; p = 0.04 (X2 test
with Yates correction)
Dietary intakes marginal
deficiency (<2/3 RDA) of
vitamin B2 by 3-d record
29.6 > 0% p = 0.007 (X2 test
with Yates correction)
Dietary intakes marginal
deficiency (<2/3 RDA) of
vitamin B3 by 3-d record
N.S. (X2 test with Yates
correction)
1 values compared highest vs. lowest percentile, 2 ≥10% sites with CAL >4 mm & ≥10% sites PPD >3 mm, 3 ≥1 site with BOP. Abbreviations: 95%CI: 95% confidence interval, BOP:
bleeding on probing; CC: Case-control study, CPI: Community periodontal index, CS: cross-sectional study, d: days, mult.: multiple, N: sample size, N.S.: not significant, NHANES:
National Health and Nutrition examination Survey, OR: Odds ratio, Ref: reference, reg.: regression, RPI: Russel’s Periodontal Index, RDA: recommended dietary amount, US: United
States, vs.: versus, y: years.
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2.4. Vitamin C
Vitamin C, also known as L-ascorbic acid, acts as enzymatic cofactor in a range of essential
metabolic reactions as ascorbate [66,67]. These include hydroxylation of proline and lysine which is
needed to stabilize its collagen structure during its manufacture. This activity confers to vitamin C a
key role in the maintenance of the integrity of connective tissues such as the periodontium.
Actually, it is well known that vitamin C deficiency causes scurvy, but it is not certain whether
milder degrees of insufficiency have clinically important effects on the periodontium. Furthermore this
nutrient is involved in immunological functions, such as phagocytosis, and in wound healing. Vitamin
C insufficiency may affect immunocompetence. Moreover, ascorbic acid is also known as a powerful
antioxidant in living organisms, particularly at intracellular level [67]. A function in which some
enzyme-dependent systems cooperate recycling oxidized forms. All these functions and activities
have conferred to vitamin C an interesting potential role in periodontal health. Probably, this explains
why this nutrients has been the most studied among all vitamins in relation to periodontal disease.
Actually, the research into the relationship between vitamin C and periodontal-related diseases comes
from as far as the eighteenth century when it was observed that scurvy was fully recovered after a
treatment with oranges and lemons [68]. Since then, many experimental (Table 5) and epidemiological
studies have tried to address the relationship between vitamin C and periodontal disease. In fact, a
total of 14 reports have been selected for this review in relation to this topic. This makes this vitamin
the most represented.
Studies in animal models have been performed on male rats [57,58], in which periodontitis
was experimentally induced by placing ligature around some teeth and the effects of vitamin
C-supplemented diets were compared with standard diets. Overall, results from them endorse
the protective or therapeutic role of vitamin C on periodontal health. After disease development
by the mentioned procedure, vitamin C showed to improve bone density index (BDI) at areas
with periodontitis [58]. In relation to bone metabolism markers, the supplemented diet decreased
RANKL expression suggesting that osteoclastogenesis stimulation is diminished despite an increase in
alkaline phosphatase (AP) was also observed [58]. The analysis of additional markers has shown that
consumption of vitamin C-supplemented diets improved the values of some oxidative stress markers
(reduced glutathione (GSH) to oxidized glutathione (GSSG) ratio and 8-hydroxydeoxyguanosine
(8-OhdG)) [57], decrease myeloperoxidase (MPO) activity [43] and down-regulated the expression
of assessed pro-inflammatory cytokines (interleukin (IL)-1α and IL-1β) [57]; all associated to
experimental periodontitis.
In regard to research in humans, 15 observational studies and six randomized-controlled trials
(RCT) were found among the selected studies. Results from observational studies are contradictory
and often depend on parameter evaluated. Concerning dietary intake, several studies have reported a
negative association with periodontal disease. Among cross-sectional studies, one of most interesting
evidences are provided by Nishida et al. [69] who reported a dose-dependent relationship between
vitamin C intake and the number of persons with periodontitis (defined by an average value of CAL
of 1.5 mm or higher) in a sample of 12,419 NHANES III participants. Otherwise, no relationships have
been found in other investigations. These included a cross-sectional study in 80 patients from a U.S.
dental clinic [21] already cited for previous vitamins and a case-control study in 42 patients from an
academic center in The Netherlands [70], but also a cross-sectional study in 3043 participants from
Japanese NHANES [65] where periodontitis was defined by a CPI of 3 or more. In the same sense, in
the study above that compared female adolescent with and without gingivitis [37] no differences were
observed in relation to prevalence of marginal deficiency of vitamin C intake.
In contrast, those studies evaluating vitamin C levels in blood mostly supported a negative
association between nutritional status and periodontal disease. Among them, there was a cohort study
in a younger group of Indonesian villagers reporting a negative correlation between plasma vitamin C
level and CAL after 15 years [71]. Additionally, participants with vitamin C deficiency displayed higher
CAL than those with no depletion or normal plasma values [71]. Likewise, case-control studies also
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confirmed this association [70,71]. Among them, one where authors subdivided periodontitis patients
into systemically healthy subjects and those type 2 diabetes mellitus (DM2) patients [72]. However,
these last results may be questioned because the report did not offer details about possible pair-matched,
confounding analysis or prevention of detection bias. Interestingly, the other case-control study, cited
above [70], did not find significant association with dietary intakes. In turn, in the cross-sectional study
in dental clinic patients [36] did not find associations with RPI as occurred with dietary intakes. Still,
vitamin C levels were negatively associated with periodontitis prevalence in other study based on the
NHANES III data, previously mentioned [38]. Furthermore, this association was significant depending
on periodontitis definition criteria. Despite many studies reported an absence of association between
vitamin C and periodontitis, it is important to note that those based in great and representative samples
did it. Moreover, there was a wide variety in these studies concerning definitions and periodontal
health-related clinical parameters used, which could explain in part the differences found among their
results. On the other hand, some epidemiological studies have also focused on antibody levels against
certain microorganism negatively related to periodontal health. In one of this, plasma concentrations
of vitamin C were inversely correlated with the number of oversensitive to P. gingivalis [73]. On the
other hand, when total immunoglobulin G (IgG) levels to several oral bacteria were taken into account,
there was no association with dietary intakes of vitamin C in a sub-cohort aged 35–70 years old from
the European Prevalence of Infection in Intensive Care Study [74]. This suggest that P. gingivalis is
particularly interesting for periodontal disease pathogenesis.
Moreover, dietary vitamin C effects in the presence of typical risk factors also have been evaluated.
Among others, the possible interaction with smoking has been evaluated in studies restricted to a
particular subgroup or by means of stratification. In the study by Nishida et al. [69] with NHANES
III data from current and former smoker subjects, a dose-dependent relationship between vitamin C
intake and periodontal disease diagnosis was reported, being stronger in current smokers. However,
serum levels were negatively associated with periodontitis prevalence in other study based also
on NHANES III data when only never-smokers were included, even after used a more restrictive
criteria to define periodontitis [38]. Similarly, studies stratified by age or restricted to elderly people
have been performed. Two cohort studies restricted to old segment of population have provided
evidences for negative associations among disease and vitamin C intake. In a subset of 73 years old
subjects from Niigata study, the number of teeth with periodontal disease progression for 2 years of
follow-up was shown to be inversely affected by vitamin C intake, even after adjustment for potential
confounder [34]. Aged subjects from the same survey showed similar associations when follow-up time
was of 8 years [75]. In a cross-sectional study, elderly participants from Niigata city (Japan) exhibited a
weak negative association although significant among CAL and serum vitamin C levels, even after
adjustment for potential confounders in multivariate regression analysis [61]. Curiously, in a stratified
cohort study in Americans that participated in the first National Health and Nutrition Examination
Survey (NHANES I) and NHANES I Epidemiologic Follow-up Study (NHEFS) with a follow-up of
approximately 10 years in a population of all ages, an inverse relationship with dietary intake was
noted but only in younger persons (25–59 years) [76]. Therefore, although age and smoking can be
related with efficacy of vitamin for periodontal disease prevention, this can depend on population
features. In addition, results from a study in rats also have suggested that vitamin C supplementation
could contribute to prevent the effect of other nutritional risk factors associated with this disease,
namely cholesterol amount in the diet, on alveolar bone density [59]. This effect was also associated to
a decrease in osteoclast differentiation markers and serum 8-OHdG initiating that it act by mechanisms
related to oxidative stress and osteoclastogenesis regulation as occurred in similar models fed standard
diets [57,58]. All these suggest that vitamin C also can contributed to prevent the effect of other risk
factors of periodontal health the use of supplements could result particularly interesting for subjects
showing such risks.
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Table 5. Observational studies on vitamin C association with periodontal disease.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional Status
Assessment Periodontal Status Analysis Results (p-Value) Main Results/Conclusions Ref
CS
NHANES III
Participants (US)
Both; ≤20 y;
N = 12,419
Dietary intake by
24-h recall (0–29,
30–59, 60–99,
100–179, & ≥180 mg)
- Periodontal disease 3
OR 1 = 1.28 (95%CI: 1.02–1.43);
p < 0.05 for trend (mult. logistic
reg.) in current smokers
Negative association in
smokers, it was stronger in
former smokers than current
tobacco users
[69]
OR 1 = 1.21 (95%CI: 102–1.43);
p < 0.05 for trend (mult. logistic
reg.) in former smokers
CS
NHANES III
participants (US)
Both; ≤20 y;
N = 11,480
- Serum levels
(quintiles)
Mild periodontitis 4
OR 2= 0.82 (95%CI: 0.76–0.87);
p = 0.0001 (mult. logistic reg.) in
non-restricted model
Negative association, it was
stronger with severe disease,
& in never-smokers
[38]
OR 2= 0.71; (95%CI: 0.58–0.86);
p = 0.001 for trend (mult. logistic
reg.) in model restricted to
never-smokers
Severe periodontitis 5
OR 2 = 0.76 (95%CI: 0.69–0.84);
p = 0.0001 for trend) in
non-restricted model
OR 2= 0.8 (95%CI: 0.71–0.89);
p = 0.0001 for trend (mult. logistic
reg.) in model restricted to
never-smokers
CS Niigata studyparticipants (Japan) Both; 70 y; N = 413 - Serum levels CAL
β = −0.04 (95%CI: −0.06 to
−0.005); p < 0.05 (mult. linear reg.) Negative association [77]
CS Dental clinicpatients (US) Both; N.A.; N = 80
Dietary intakes by
24-h recall Serum levels RPI
N.S. (mult. linear reg with R2
improvement) No associations [36]
CS NHANESparticipants (Japan)
Both; ≥20 y;
N = 3043
Dietary intake by
24-h recall - CPI = 3–4 N.S. (mult. logistic reg.) No associations [65]
CS
Men from 2
populations
(Finland & Russia)
Male; 48.2 ±
13.6/44.8 ± 11.4 y; N
= 431
- Plasma levels
Serum IgG against Pg r = −0.22; p < 0.001 (Pearsoncorrelation analysis) Negative association with
anti-Pg IgGs level [73]
Serum IgG against
Agact N.S. (Pearson correlation analysis)
CS
Cancer-free
individuals from an
EPIC sub-cohort
(Europe)
Both; 35–70 y;
N = 395 Dietary intake * -
Total IgGs levels for 25
oral bacteria 6 N.S. (generalized linear models) No association [74]
CC Non-smokersoutpatients (India) Both; 30–60 y; N = 60 - Serum levels
DM2 & periodontal
disease-affected7 only
periodontal
disease-affected &
healthy
0.93 (±0.24) > 0.335 (±0.5) > 0.292
(±0.004); p < 0.001 (student t test)
Subjects with periodontal
disease showed lower vitamin
C levels
[72]
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Table 5. Cont.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional Status
Assessment Periodontal Status Analysis Results (p-Value) Main Results/Conclusions Ref
CC
Patients from an
academic center
(NL)
Both; ≥21 y; N = 42
- Levels in plasma
Periodontitis-affected 8
vs. healthy
8.3 (±3.9) < 11.3 (±5.2) mg/L;
p = 0.03 (N.A.)
Subjects with periodontitis
showed lower plasma levels
of vitamin C
[70]No. of servings (of
≥31, 30 to 2, or <2
mg per 100 mg) by
3-d record
N.S. differences
Total intake by 3-d
record N.S. differences
CC
Non-smokerss
adolescents (Italy
Female; 17–19 y;
N = 56
Dietary intake by
3-d record
- Gingivitis affected
9 vs.
non-affected
N.S. differences (Student t test)
No association [37]Dietary intakes
marginal deficiency
(<2/3 RDA) by 3-d
record
N.S. differences (X2 test)
RC (2 y) Niigata studyparticipants (Japan) Both; 73 y; N = 264
Dietary intake
(tertiles) by BDHQ -
No. of teeth with
periodontal disease
progression 10
IRR 2 = 0.72 (95%CI: 0.56–0.93);
p < 0.05 for trend (mult.
logistic reg.)
Negative association [41]
C (8 y) Niigata studyparticipants (Japan) Both; 71 y; N = 224 -
Serum levels
(tertiles)
Periodontal disease
events 11
RR 2 = 1.30 (95%CI: 1.16–1.47);
p < 0.05 for trend (mult.
logistic reg.)
Negative association [77]
RC (3 y) Residents from avillage (Indonesia)
Both; 33–43 y;
N = 123 -
Plasma levels (>2;
2–3.9; or ≥4.0 mg/L) Mean CAL
β = −0.199; p = 0.029 (mult.
linear reg.) Negative association [72]
C (10 y) NHEFS & NHANESI participants (US)
Both; 25–74 y;
N = 10,523
Dietary intake (%
NHANES standards)
by 24-h recall & FFQ
- Total teeth lost
β = −0.0031 (±0.0011); p = 0.01
(mult. linear reg.) in 25–59 y old
subjects Negative association only in
younger subjects [76]
N.S. (mult. linear reg.) in 60–74 y
old subjects
1 values compared lowest vs. highest percentile, 2 values compared highest vs. lowest percentile, 3 mean CAL ≥1.5 mm, 4 ≥1 site with CAL ≥4 mm & PPD ≥4 mm, 5 ≥2 mesiobuccal sites
with CAL ≥5 mm & 1 mesiobuccal sites with PPD ≥4 mm, 6 Pg ATCC 33277 & ATCC 53978, Agact ATCC 29523 & ATCC 43718, Tannerella forsythia ATCC 43037, Fusobacterium nucleatum
ATCC 25586, Fusobacterium periodontium ATCC 33693, Fusobacterium polymorphum ATCC 10953, Prevotella intermedia ATCC 25611, Prevotella melaninogenica ATCC 25845, Prevotella
nigrescens ATCC 33563, Veillonella atypica ATCC 17744, Veillonella parvula ATCC 10790, Bifidobacterium dentium ATCC 27534, Corynebacterium matruchotii ATCC 14266, Enterococcus faecalis
ATCC 29212, Parvimonas micra ATCC 33270, Peptostreptococcus anaerobius ATCC 27337, Streptococcus intermedius ATCC 27335, Streptococcus mitis ATCC 49456 & Streptococcus salivarius ATCC
7073, 7 generalized CAL ≥5 mm & BOP, 8 ABL >1/3 of the root length in >1 tooth per quadrant, 9 ≥1 site with BOP, 10 CAL ≥3 mm in ≥1 site, 11 No. of teeth with a loss of CAL ≥3 mm.
Abbreviations: 95%CI: 95% confidence interval, Agact: Aggregatibacter actinomycetemcomitans, BOP: Bleeding on probing; C: Cohort study, CAL: Clinical attachment level, CC: Case-control
study, CEJ: Cementum-emanel junction, CS: cross-sectional study, EPIC: European Prospective Investigation into Cancer and Nutrition, DM1: Diabetes mellitus type 1, DM2: Diabetes
mellitus type 2, FBG: Fasting blood glucose, FFQ: food frequency questionnaire, IgG: Immunoglobulin G, IRR: Incidence rate ratio, IWCPDC: International Workshop for the Classification
of Periodontal Diseases & Conditions in 1999, NHANES I: First National Health and Nutrition Examination Survey, NHANES III: Third National Health and Nutrition Examination
Survey; NHEFS: NHANES I Epidemiologic Follow-up Stud, NL: Netherlands, OR: Odds ratio; Pg: Porphyromonas gingivalis, PBMC: Peripheral blood mononuclear cells, PI: Plaque index;
PMN: Polymorphonuclear neutrophils, PPD: Periodontal probing depth; RBG: Random blood glucose, Russell’s periodontal index; RR: Relative risk, US: Unite States, vs.: versus, y: years.
* by extensive quantitative dietary questionnaires or semi-quantitative FFQ or combined food records & questionnaires quartiles.
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Despite evidences collected from animals and epidemiological studies, none intervention in
humans presented here reported clear positive effects for vitamin C supplementation on healthy
subjects or periodontitis patients. Positive effects were noted only with increases of intakes through
vitamin C-rich foods introduced on diet. Main finding supporting this idea comes from a cross-over
trial where the same individuals chewed on sugar free gum contained vitamin C, non-vitamin C
and no gum for three months following by scaling treatment. Vitamin C-containing gum led to an
improvement at gingival bleeding (GB) level, although interestingly, calculus score and visible plaque
were diminished with the two gums. However, it is important to note that other clinical measurements
related to periodontal disease like PPD or CAL were not taken, so treatment implications were not
deeply known [53].
In relation to this parameters, another study, in this case in children, tested the effect of chewing
on vitamin C enriched tablets on RPI but no effect were observed compared with mannitol-containing
tablets that were used as placebo [54]. Notwithstanding, risk of performance bias was present because
of variability in consumption. Likewise, no effects also was noted in other two investigations in
patients that received root and planning therapy before a period of vitamin C supplementation [55,56].
However, not blinding nor detail about selection comprised results in one of them. Problems in
obtaining positive results could be due to used dosages or its combination with treatment more
effective [55,56] that may occult the effect of this nutrient. On the other hand, maybe correct vitamin C
intake is necessary to avoid periodontal problems but when the pathological state has been instituted,
a supplementation with vitamin C is not enough to revert it to the healthy state
2.5. Vitamin E
Vitamin E activity is exerted by a set of lipid-soluble food compounds featured by a
phenolic-chromanol ring linked to an isoprenoid side chain. These are termed as tocopherols or
tocotrienols depending on the phenolic-chromanol ring were saturated or unsaturated, respectively. In
addition both can present four forms according to the number and position of methyl groups on the
ring: α, β, γ and δ [78]. As expected, all these forms have been taken into account for this review. For
this set of compounds, four observational studies in humans (Table 6) and two experimental studies
in rats were found (Table 2). Regarding research in humans, there were two cohort studies and two
cross-sectional studies. Serum levels of α-tocopherol have been inversely associated with mean PPD
and periodontitis (defined according to CDC/AAP criteria) in a subset of participants in the 1999–2001
NHANES. However, serum levels of γ-tocopherol showed a most modest association with subjects in
the interquartile range displaying a significantly lower mean PPD than those in the highest quartile [3].
The rest of observational studies were restricted to elderly subjects [41,42,77]. Two cohort studies
has provided complementary data supporting the positive effect of vitamin E on the prevention of
periodontal disease progression (defined by an annual loss of CAL equal or higher than 3 mm or
higher at any site over the study period) but they only were performed in elderly people. One of them,
that have been previously reported [41], estimated dietary intakes of vitamin E [26] and the other
evaluated serum levels of α-tocopherol [77]. However, this survey could be affected by a possible
detection bias due to self-assessment and no inclusion of supplement as we pointed out previously.
In contrast, no association of periodontitis with α-tocopherol or γ-tocopherol levels was found in
PRIME study participants [42], although it was a cross-sectional study. Anyway, both studies reporting
associations were performed with subjects form Niigata city (Japan), it would be interesting evaluate
this relationship in cohorts from other population to validate this association, at least in old people.
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Table 6. Observational studies on vitamin E association with periodontal disease.
Study
Type Sample Sex; Age; N
Dietary Intake
Assessment
Nutritional Status
Assessment Periodontal Status Analysis Results (p-Value)
Main
Results/Conclusions Ref
CS
1999–2001 NHANES
participants (US)
Both; adults
N = 4708
-
Serum levels of
α-tocopherol adjusted by
cholesterol levels
(quartiles)
mean PPD
Mean 1 = 1.07 (95%CI:
1.00–1.15); 0.96 (95%CI: 0.90,
1.02) p = 0.005 for trend (mult.
logistic reg.)
Non-linear inverse
association of
α-tocopherol levels
with mean PPD &
periodontitis
[3]
CAL N.S. (mult.logistic reg.)
Periodontitis 3
OR1 = 1.65 (95%CI: 1.26–2.16);
p = 0.005 for trend (mult.
logistic reg.)
Serum levels of
γ-tocopherol adjusted by
cholesterol levels
(quartiles)
CAL N.S. (mult.logistic reg.)
mean PPD N.S. (mult.logistic reg.)
Periodontitis 3 N.S. (mult.logistic reg.)
CS
PRIME participants
(Northern Ireland)
Male; 60–70 y;
N = 1258
- Serum levels of
α-tocopherol &
γ-tocopherol (quintiles)
Low-threshold 4
Periodontitis N.S. (mult.logistic reg.) No associations [42]
High-threshold 5
periodontitis N.S. (mult.logistic reg.)
C (8 y) Niigata studyparticipants (Japan) Both; 71 y; N = 224 -
Serum levels of
α-tocopherol (tertiles)
Periodontal disease
events 6
RR 2 = 1.15 (95%CI: 1.04–1.28);
p < 0.05 for trend
(mult.logistic. reg.)
Negative association [75]
RC (2 y) Niigata studyparticipants (Japan) Both; 75 y; N = 264
Dietary intakes of
vitamin E (tertiles)
by BDHQ
-
No. of teeth with
periodontal disease
progression 7
IRR 2 = 0.55 (95%CI:
0.42–0.72); p < 0.005 for trend
(mult. logistic reg.)
Negative association [42]
1 values compared lowest vs. highest percentile, 2 values compared highest vs. lowest percentile, 3 sum of mild, moderate, and severe periodontitis according to CDC/American Academy
of Periodontology criteria, 4 ≥2 teeth with non-contiguous inter-proximal sites with CAL ≥6 mm & 1 PPD ≥5 mm, 5 ≥15% of all sites measured CAL ≥6 mm & ≥1 site with PPD
≥6 mm, 6 No. of teeth with CAL ≥3 mm, 7 CAL ≥3 mm in one site. Abbreviations: 95%CI: 95% confidence interval, BDHQ: brief diet-history questionnaire, C: cohort study, CAL:
clinical attachment loss, CS: cross-sectional study, IRR: incidence rate ratio, mult.: multiple, N: sample size, N.S.: not significant, OR: odds ratio, PPD: preiodontal probing depth, PRIME:
Prospective Epidemiological Study of Myocardial Infarction, reg.: regression, RR: relative risk, US: United States, y: years.
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Because of their liposoluble properties, vitamin E is able to incorporate in biological membranes
where it inhibits peroxidation of lipids [79,80] due to this well-known antioxidant activity [80]. As
consequence, vitamin E stops the production of ROS formed when fat undergoes oxidation [78]
preventing propagation of damage to cell membranes by peroxyl radicals formed by the oxidation
of lipids to stabilize the membrane structure by terminating the free radical chain reaction [78–80].
Research in animals has allowed to evaluate the use of vitamin E supplements on periodontal diseases
and its possible role on ROS and inflammatory processes associated with this conditions [46,47]. In
a rat model of periodontitis induced by ligatures, vitamin E supplements prevented increases in
malondialdehyde levels and immunoreactivity to inducible nitric oxide synthase (iNOS), but did not
decrease ABL [61]. However, in other rats stressed on a rotational device or not stressed, supplements
had a protective effect on bone loss in all cases, but there was no interaction with stress condition [62].
Therefore, experiments in rats suggest that vitamin E supplements would prevent oxidative stress
associated to periodontitis [46,47], but its potential for periodontal disease treatment is not clear since
they did not decreased ABL always [46]. In any case, there are no studies evaluating its possible use as
nutraceutical in relation to this disease in humans.
3. Materials and Methods
3.1. Selection Criteria
Inclusion and exclusion criteria for the selection of papers to be reviewed were established prior
to commencement of the literature search. For this review, researches using both humans and animals
were included, but only written in English language. All relevant studies investigating the association
between periodontal disease and nutrient dietary intake or nutritional status markers were included,
even if they focused only on people belonging to certain age groups or on subjects with any special
physiological condition or illness (pregnancy, menopause, diabetes mellitus or others). Studies had to
assess periodontal health condition, including also number of teeth or edentulism. However it was
considered that it could be due to other pathologies. Regarding study design, cross-sectional, cohort
and case-control studies were selected within those belonging to observational type. On the other
hand, only RCT were accepted from experimental surveys collected. Additionally, interventional trials
with nutrient combinations were excluded for individual assessment of each nutrient, although some
exceptions were made, which will be discussed later. Similar exclusion criteria were used in the case of
animal studies.
3.2. Information Source and Search Terms
The electronic database of the National Library of Medicine (Washington, DC, USA) (MEDLINE:
PubMed) was used to select appropriate papers. We first derived two themes that were then combined
by using the Boolean operator “AND”. Each theme was created by using the operator “OR” to
search for terms appearing as either explorer text words or Medical Subjects Headings (Mesh), when
they existed and it was not contained within other, also used. The selected periodontal disease
related terms were: periodontal, periodontitis, gingivitis and it was also included the following
outcome measurement related to periodontal disease: “Alveolar Bone Loss” [Mesh] OR “Periodontal
Diseases” [Mesh] OR “Periodontal Attachment Loss” [Mesh] OR “Periodontal Index” [Mesh] OR
“Gingival Hemorrhage” [Mesh] OR “periodontal disease” OR periodontitis OR “alveolar bone loss”
OR “alveolar bone resorption” OR “tooth attachment” OR “tooth mobility” OR “gingivitis” OR
“clinical attachment level” OR “periodontal attachment level” OR “attachment loss” OR “periodontal
pocket” OR “pocket depth” OR “probing depth” OR “bleeding on probing” OR “gingival bleeding”
OR “Gingival Hemorrhage” OR “gingival index” OR “bleeding index” OR “periodontal index”.
In addition to this, a second theme related to nutrition or diet was created. Search terms were as
follows: “Food” [Mesh] OR “Diet” [Mesh] OR “Eating” [Mesh] OR “Nutrition Surveys” [Mesh] OR
“Nutrition Assessment” [Mesh] OR “Nutrition Therapy” [Mesh] OR “Nutrition Processes” [Mesh] OR
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“Nutritional Status” [Mesh] OR nutrition * OR nutrition OR nutrient * OR nutrient OR food OR dietary
OR diet * OR intake OR intakes OR consumption* OR consumption OR ingestion OR eating. Finally,
for each nutrient it was combined with all name synonyms, its precursors and its ionic forms present
in organism as search terms.
3.3. Search Strategy
The search strategy aimed to find both published studies in the English language from
the inception of the database until February 2018. A comprehensive literature search was run
independently by two of the review authors. At first, papers were screened by title and abstract.
Screening procedures were adjusted for higher sensitivity (with restrictive search items omitted).
Secondly, full text-papers were retrieved and selected based on the eligibility criteria, and duplicated
studies were excluded. Titles without abstract but which suggested that they were related to the
objectives of this review were selected for full text screening to screen the full text. Inconveniently,
our methodological approach did not allow to obtain articles nor available on line, or published in
journals whose rights had not been acquired by University of Granada at the date of search. Review
authors’ disagreements or inconsistencies concerning inclusion of publications or extraction of data
were discussed to eventually achieve mutual consensus.
3.4. Data Collection Process, Data Items and Summary Measures
The quantitative data extracted from papers included specific details about the interventions,
populations, study methods, and significant outcomes for the review question and specific objectives.
Data from eligible studies were independently evaluated. When they were available, outcome
measurement means or differences between means, and their standard deviations between groups like
clinical outcomes for periodontal disease, nutritional status or dietary intakes, depending on study,
were included in our description of the results. In the same way, association measurements, such as
correlation or regression coefficients, IRRs, ORs, RRs, HRs and their corresponding 95%CI, as well as
significance levels considered or p-values were considered, but only if significant associations and/or
differences were found.
3.5. Quality Assessment and Risk of Bias
Subsequently, potentially relevant publications were read in full to determine their quality, mainly
through the assessment of bias risk. The methodological quality of a publication was determined in
accordance with several criteria depending on the study design. For observational studies, evaluation
and strategies to deal with them were considered in addition to risk of bias. According to the
prevention of confounding effects, the employment of randomization, only in clinical trials, matching
or restriction, were explored at design level, while the use of multivariate analysis, stratification or
frequency matching was appraised at data analysis level. Concerning the risk of bias, four types of
bias have been proposed: selection, detection, attrition and reporting bias [81]; although other authors
have simplified this classification into two categories: selection and information bias [82]. Anyway,
critical issues for prevent them present differences among design types. For cross-sectional studies,
three points were mainly evaluated: sample randomization, reliability and objectivity of variables
assessment, as well as definition of group if comparisons were made. For case-control studies, it was
also taken into account the objectivity and reliability of subjects evaluations including here category
definitions and exposure evaluation methods. Lastly, for cohort studies, it was considered the exposure
and status definition and measurement. In the same way, differences in duration, reliability and
objectivity of outcome assessment were considered. Also, the presence of differences on intensity of
medical surveillance, loss of follow-up, missing data treatment, and differences related to the outcome
or exposure of risk factors between those who drop out and those who stay in the study were taken
into account. Inclusion criteria and/or sources of data or individuals background were considered
for the establishing of the sample external validity and set of population represented. Additionally,
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grouping criteria in data analysis were account, when they were presented, especially if they were
selected post hoc from alternative options.
On the other hand, Intervention trials were assessed according to Cochrane guidelines, which take
into account five type of bias: selection, performance, detection, attrition and reporting bias [83].
Based on their recommendations, the following domains were evaluated: sequence generation
(randomization), allocation concealment, blinding of participants, operators and/or examiners,
incomplete outcome data and selective reporting. In function of the results of this assessment, degree
of risk (high, low or unclear) was established for each type of bias, as well as its possible magnitude
and direction. The risk of bias and its possible effects were summarizing for each outcome within each
study. Finally, it was summarized for review as a whole, where it was possible.
4. Conclusions
The aim of this review was to analyze the main published data until February 2018 on the
relationship between vitamins and the development and progression of periodontal disease both
in humans and animals to understand the potential benefits and risks of supplementation with
vitamins on this pathology. Although some studies suggest that improving or maintaining an optimal
nutritional status in relation to vitamins, particularly for vitamins D and C, in general, evidence
supporting certain grade of relationship of vitamins with periodontal health is reduced and there
are limitations that should be overcome. Among others, the number of experimental studies is
reduced yet, particularly in humans; likewise, reported effects are usually too small to indicate
the magnitude of therapeutic supplements, even when used as an adjunct to periodontal therapy.
Importantly, for certain vitamins, interventions in humans did not reported clear positive effect despite
evidence provided by observational and animal studies as occurred with vitamin C supplementation.
Concerning observational studies, the use of dietary supplement was ignored or normalized with the
same value for all subjects in some of them. Moreover, there was a wide variety in observational studies
concerning definitions and periodontal health-related clinical parameters used, which could explain
in part the differences found among their results. In addition to that, few articles deepened on the
mechanisms under the observed relationships. On the other hand, several studies have been performed
on subgroups with conditions that represent a risk for bone health such as age, menopause or smoking
status. The use of supplements could result particularly interesting for subjects showing such risks.
For instance, different studies on vitamin D suggest that starting to take vitamin D supplementation
from middle age could be particularly interesting for preventing periodontal disease advancement.
Problems in obtaining positive results from experimental studies could be due to used dosages
or its combination with treatment more effective that may occult the effect of this nutrient. In spite
of this, there is a paucity of well-designed, long-term experimental studies to ascertain the direct
effects of dietary supplements on the outcomes on periodontal diseases. Therefore, the results and
methodological approaches of many of the presented studies makes provided evidence no definitive
to clearly consider as “nutraceutical” any of the vitamins included in this review. In this sense, is
particularly important to note that supplementation is not enough to revert the periodontium to a
healthy state, or at least at the moment there is not enough evidence supporting this. Therefore, the
use of vitamin supplements in any case can replace other therapies. Notwithstanding, the use of
supplements with several or certain vitamins for people under physiological or pathological conditions
that increase the risk of suffers bone pathologies or pathological alterations could contribute to protect
periodontal tissues. This suggests the existence of putative risk groups to recommend the consumption
of nutraceutical in the context of periodontal health, but more studies are needed to confirm this and
clarify what vitamins use for each case, as well as dosages and taking frequency.
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